Joanna Firko
Research Subjects
Joanna Firko has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Agata Sobczak
University Clinical Center in Gdańsk Dębinki 7, 80-952 Gdańsk, Poland
1 shared publication - Anna Waldman
Poznan University of Medical Sciences, ul. Aleksandra Fredry 10, 61-701 Poznań, Poland
1 shared publication - Kalina Kreft
Karol Marcinkowski University Hospital in Zielona Góra Zyty 26, 65-046 Zielona Góra, Poland
1 shared publication - Lena Głuszkiewicz
University Clinical Center in Gdańsk Dębinki 7, 80-952 Gdańsk, Poland
1 shared publication - Magdalena Wolff
Karol Marcinkowski University Hospital in Zielona Góra Zyty 26, 65-046 Zielona Góra, Poland
1 shared publication - Maja Kowalczyk
Karol Marcinkowski University Hospital in Zielona Góra Zyty 26 65-046 Zielona Góra, Poland
1 shared publication
Latest Publications
- Open Access
- 2 October 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 76239
Safety of Long-Term Creatine Supplementation in Relation to Kidney, Liver, and Skeletal Muscle Function and Reported Adverse Effects: A Narrative Review
Background: Despite robust evidence supporting the ergogenic and therapeutic benefits of creatine, safety concerns regarding long-term supplementation—particularly regarding kidney, liver, and muscle health—persist. Aim: This narrative review evaluates the safety of long-term creatine supplementation on renal, hepatic, and skeletal muscle function, as well as reported adverse events. Materials and Methods: A narrative analysis of 22 scientific publications (randomized controlled trials, systematic reviews, observational studies, and experimental models) was conducted across healthy, athletic, aging, female, and clinical populations. Results: At recommended dosages, long-term creatine supplementation causes no clinically significant renal or hepatic impairment. Observed increases in serum creatinine reflect physiological turnover rather than renal dysfunction. Creatine is well-tolerated by skeletal muscle and supports muscle mass maintenance, particularly in older adults. Reported adverse effects are mild and transient, primarily involving gastrointestinal discomfort or short-term body mass changes. Conclusions: Current evidence confirms the safety of long-term creatine supplementation when used appropriately. Further research is warranted in populations with pre-existing renal or hepatic conditions.
- 2 October 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 76239
Open AccessSafety of Long-Term Creatine Supplementation in Relation to Kidney, Liver, and Skeletal Muscle Function and Reported Adverse Effects: A Narrative Review
Background: Despite robust evidence supporting the ergogenic and therapeutic benefits of creatine, safety concerns regarding long-term supplementation—particularly regarding kidney, liver, and muscle health—persist. Aim: This narrative review evaluates the safety of long-term creatine supplementation on renal, hepatic, and skeletal muscle function, as well as reported adverse events. Materials and Methods: A narrative analysis of 22 scientific publications (randomized controlled trials, systematic reviews, observational studies, and experimental models) was conducted across healthy, athletic, aging, female, and clinical populations. Results: At recommended dosages, long-term creatine supplementation causes no clinically significant renal or hepatic impairment. Observed increases in serum creatinine reflect physiological turnover rather than renal dysfunction. Creatine is well-tolerated by skeletal muscle and supports muscle mass maintenance, particularly in older adults. Reported adverse effects are mild and transient, primarily involving gastrointestinal discomfort or short-term body mass changes. Conclusions: Current evidence confirms the safety of long-term creatine supplementation when used appropriately. Further research is warranted in populations with pre-existing renal or hepatic conditions.